Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells

Han Ki Lee1, Heui Min Lim1, See-Hyoung Park2

  • 1Department of Biological Science, Gachon University, Seongnam 13120, Korea.

Insights

CRISPR/Cas9 gene editing effectively inhibited Hepatocyte Growth Factor (HGF) in hepatocellular carcinoma (HCC) cells, suppressing proliferation and inducing apoptosis. This study highlights HGF as a therapeutic target for HCC treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Editing Technologies

Background:

  • Hepatocellular carcinoma (HCC) growth is promoted by Hepatocyte Growth Factor (HGF).
  • CRISPR/Cas9 is a gene-editing tool for targeted DNA modification.
  • Investigating HGF's role in HCC apoptosis is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the apoptotic effects of CRISPR/Cas9-mediated HGF inhibition in HCC cells.
  • To evaluate the impact of targeting HGF on HCC cell proliferation, migration, and invasion.

Main Methods:

  • Constructed Crispr-HGF plasmid for targeted HGF gene editing.
  • Utilized real-time PCR, cell counting, colony formation, migration, and invasion assays.
  • Performed cell cycle analysis, annexin V/PI staining, and Western blot to assess apoptosis and molecular changes.

Main Results:

  • Crispr-HGF significantly downregulated HGF mRNA and protein expression in HCC cells.
  • Inhibition of HGF suppressed HCC cell viability, proliferation, migration, and invasion.
  • Crispr-HGF transfection induced cell cycle arrest and apoptosis, regulating key signaling pathways.

Conclusions:

  • Targeting HGF with CRISPR/Cas9 effectively suppresses HCC cell proliferation and induces apoptosis.
  • This approach demonstrates potential for novel HCC therapeutic strategies by inhibiting HGF.